Results
1 -
10 of
22
(Click
here to explore results)
- Orphan Drugs and Rare Diseases, Chapter 15 The Discovery and Development of Ruxolitinib for the Treatment of Myelofibrosis. Kris Vaddi
, 2014
, Pages 419-439
- Orphan Drugs and Rare Diseases, Contents
, 2014
, Pages P013-P022
- Kinase Drug Discovery: Modern Approaches, CHAPTER 5 Small Molecule Macrocyclic Kinase Inhibitors. Anders Poulsen, Brian Dymock
, 2019
, Pages 97-127
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 5 Pyrazoles. Carsten S. Kramer
, 2016
, Pages 115-131
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, CHAPTER 15 COVID-19 Pharmacotherapy – Present and Future. Deepak Kumar, Ravi Mangalia, Mahadev Meena, Varatharajan Sakthivadivel, Gopal Krishna Bohra, Stafford Warren
, 2022
, Volume 1
, Pages 412-454
- Orphan Drugs and Rare Diseases, Subject Index
, 2014
, Pages 448-463
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, CHAPTER 6 Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials. Ssang-Goo Cho, Claude Hughes, Iyer Mahalaxmi, Mohana Devi Subramaniam, Balachandar Vellingiri, Stafford Warren
, 2022
, Volume 1
, Pages 136-164
- Orphan Drugs and Rare Diseases, Chapter 4 Treating Rare Diseases: Business Model for Orphan Drug Development. Cory Williams
, 2014
, Pages 83-111
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 1 Privileged Scaffolds in Medicinal Chemistry: An Introduction. Eliezer J. Barreiro
, 2016
, Pages 1-15
- Kinase Drug Discovery: Modern Approaches, CHAPTER 4 Covalent Inhibition of Kinases. Gerjan de Bruin, Tjeerd Barf
, 2019
, Pages 61-96